探讨复方地茯口服液辅助DCF化疗方案治疗胃癌的临床疗效

To Investigate the Clinical Efficacy of Fu Oral Liquid Adjuvant DCF Chemotherapy on Gastric Cancer

目的探讨复方地茯口服液辅助DCF化疗方案治疗胃癌的临床疗效。方法 80例胃癌晚期患者,随机分为实验组和对照组,每组40例。对照组患者行DCF化疗方案;实验组患者在基础上服用复方地茯口服液。结果两组近期疗效对比,实验组优于对照组,P<0.05;实验组改善率87.5%优于对照组75.0%,对比差异显著,P<0.05。结论复方地茯口服液辅助DCF化疗方案治疗胃癌近期疗效较好,可明显改善患者生活质量,值得临床推广应用。

Objective To investigate the clinical effect of compound oral liquid of Di Fu adjuvant DCF chemotherapy in the treatment of gastric cancer.Methods80 cases of patients with advanced gastric cancer, were randomly divided into experimental group and control group, each group of 40 cases. The control group was treated with DCF chemotherapy; the patients in the experimental group received compound oral liquid on the basis of fu.Results The two groups of curative effect comparison, the experimental group was better than the control group, the experimental groupP〈 0.05; the improvement rate 87.5% higher than 75% in control group, had significant differences,P〈 0.05.ConclusionCompound oral liquid of Di Fu assistant DCF chemotherapy in the treatment of gastric cancer has good curative effect, can significantly improve the quality of life of patients, is worthy of clinical application.